DNA constructs. Coding region from DNA sequences for human caspase-7 (GenBank accession number NM_001227.4), human caspase-3 (NM_004346.4), murine caspase-7 (NM_007611.2), and murine caspase-3 (NM_001284409.1) were subcloned into pET-23b(+) vector (Novagen) to obtain caspases with a 6xHis-tag at the C terminus; coding region for XIAP (X-linked inhibitor of apoptosis protein] extended Bir2 domain [baculovirus inhibitor of apoptosis protein (IAP) repeat 2; residues 124-260; NM_001167.3) was subcloned into pET-15b(+) vector (Novagen) to obtain a 6xHis-tag at the N terminus. DNA encoding human PARP-1 [poly(ADP-ribose) polymerase 1;NM_001618.4] subcloned into pCMV-Tag2B was used in this study; this vector introduces an Nterminal FLAG-tag with a linker. A GST (glutathione S-transferase)-fused caspase-7 NTD (Nterminal domain) was obtained by subcloning the coding sequence for residues 1-65 of caspase-7 into the pGEX-KG vector; this vector adds an N-terminal GST protein. All deletion constructs were made using PCR to introduce a new initiating methionine or a stop codon, amino acid substitutions were made by overlapping PCR (polymerase chain reaction), and all DNA constructs were sequenced to ensure their integrity.
(25.6 kDa) and through an Amicon Ultra 3K to concentrate the NTD. The purity of the NTD was assessed by SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis), and the concentration was determined using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific).
Cell culture and transfection. AD-293 (Agilent) caspase-7 knockout (KO) cells (293 C7KO ; generated using the CRISPR/Cas9 gene editing system), RAW 264.7, and HCT 116 (American Type Culture Collection) were cultivated in Dulbecco's modified Eagle medium (DMEM) supplemented with fetal bovine serum (FBS; 10% v/v), penicillin, streptomycin, and L-glutamine (2 mM) (all cell culture reagents from Wisent). Every 2-3 days, cells were transferred to a new dish with fresh medium. 293 C7KO cells were transfected using Lipofectamine 2000 reagent (Invitrogen) following the manufacturer's protocol; cells were harvested 48 h post-transfection.
Cleavage assays. Cells containing over-expressed PARP-1 proteins were obtained by transfection as described above. For cell extracts preparation, cells were washed with PBS (phosphate-buffered saline), detached using a cell scraper in PBS, pelleted by centrifugation, and frozen at -80°C. The following day, the cell pellet was thawed on ice, resuspended in ice-cold lysis buffer [50 mM HEPES (pH 7.4), 100 mM NaCl, and 1% (v/v) Nonidet P-40] containing general non-caspase proteases inhibitors [10 µM 3,4-dicholoroisocoumarin (3,4-DCI); 10 µM E-64; 10 µM leupeptin; and 1 mM 1,10-ortho-phenanthroline; Sigma-Aldrich], and incubated on ice for 30 min. These mild conditions are not expected to result in DNA leaking from nuclei, and cleavage and activation of endogenous apoptotic caspase. The lysate was centrifuged at 18,000 x g for 15 min and the soluble fraction was recovered, aliquoted, and stored at -80°C until needed. The protein concentration was determined using the Pierce BCA Protein Assay Kit. The different PARP-1 proteins were quantified by immunoblotting and densitometry (VersaDoc 4000mp imaging system and QuantityOne software; BioRad) and compared to wild-type PARP-1 level so that each cleavage assays are performed using the same quantity of PARP-1 protein at the same final protein concentration. For the cleavage assays, 2 µg of cell lysate were incubated in 10 µL caspase buffer (see above) at 37°C with pre-heated (20 min at 37˚C) active-site titrated caspase (0.1-1,600 nM) for 30 min. For every series of cleavage assays, a sample without caspase was setup and incubated for 30 min to ensure that no endogenous caspases participated in generating cleavage products; caspase-7 cannot activate other caspases (3) . The reactions were stopped by adding SDS-PAGE loading buffer and by boiling the samples. The cleavage of substrates other than PARP-1 was performed similarly but using 38 µg of untransfected RAW 264.7 cell lysate (for murine caspases assays) or 10 µg of untransfected 293 C7KO cell lysate (all other substrates). In some instances (see figure legends), the following reagents were added to the cell lysate 30 min prior to performing the assays: purified NTD (0-250 µM), desoxyribonuclease I (DNase I, 2 units; New England Biolabs), ribonuclease (RNase A; 1 µg/ml; Thermo Fisher Scientific), RNasein (40 units; Promega Corp.), inhibited RNase (RNase A pre-incubated with RNasein), or poly(ADP-ribose) glycohydrolase (PARG, 1 ng; Trevigen). In rescue experiments, cell lysate was incubated with RNase A for 30 min, then with RNasein for another 30 min, and purified RNA (RNeasy kit from QIAGEN) was added at 5 ng/µl prior to performing cleavage assays. In the fragmented RNA experiments, purified RNA at 5 ng/µl was incubated with RNase A for 30 min, then with RNasein for another 30 min, and this cleaved RNA was added to extracts prior to performing cleavage assays.
SDS-PAGE and immunoblotting.
Samples were separated using SDS-PAGE using an ammediol buffer system (4). Proteins were transferred onto a PVDF membrane (Millipore) membrane in transfer buffer [10 mM CAPS (pH 11.0) and 10% (v/v) methanol] (5). Membranes were blocked in PBS-T-milk [PBS plus 0.1% (v/v) Tween-20 and 5% (w/v) milk (non-fat dry; Carnation)], incubated overnight with the primary antibody in PBS-T-milk or PBS plus 3% (w/v) bovine serum albumin (BSA; Wisent), and with matching horseradish peroxidase (HRP)-conjugated secondary antibody in PBS-T-milk. Immunoblots were revealed using Immobilon Crescendo (Millipore) or Clarity Max (BioRad). A VersaDoc 4000mp imaging system was used to acquire the chemiluminescence signal, and the quantification was done using the QuantityOne software on unsaturated images. The antibodies used in this study were: caspase-3 (1:1,000; 9668; Cell Signaling Technologies); caspase-6 (1:2,000; 9762; Cell Signaling Technologies); caspase-7 (1:1,000; 9494; Cell Signaling Technologies); caspase-8 (1:1000; 9746; Cell Signaling Technologies); caspase-9 (1:1,000; 9502; Cell Signaling Technologies); caspase-10 (1:2,000; M059-3; MBL); DGCR8 (1:500; sc377249; Santa Cruz Biotechnology); HRP-conjugated anti-mouse (1:5,000; 7076; Cell Signaling Technologies); HRP-conjugated anti-rat (1:5,000; 7074; Cell Signaling Technologies); FLAG M2 (1:10,000; F1804; Sigma-Aldrich); HSP90 (1:10,000; 610419; BD Pharmingen); ICAD (1:5,000; PX023A; Cell Sciences); LRRC47 (1:3,000; ab121355; Abcam); p23 (1:5,000; MA3-414; Thermo Fisher Scientific); PARP-1 C-term (1:7,500; 556362; BD Pharmingen); Penta-His (0.1 µg/ml; 34660; QIAGEN); NOP14 (1:5,000; ab157112; Abcam); RanBP2 (1:1,000; sc74518; Santa Cruz Biotechnology); RBM26 (1:2,000; ab74198; Abcam); and SR140 (1:3,000; sc398718; Santa Cruz Biotechnology). See the UniProtKB database (https://www.uniprot.org) for protein descriptions and acronyms.
Kinetic assays. The hydrolysis rate of PARP-1 was obtained using the pseudo-first-order rate equation: p = 1-e -kEt in which the proportion of cleaved full-length PARP-1 (p) as a function of time (t), the caspase concentration by (E), and the cleavage rate constant k. The analysis was done as described by Martini et al. (6) . The proportion of cleaved PARP-1 was obtained from immunoblots. Cleavage assays were done in the same conditions, which allow using k values to compare the different series of assays. For cell extracts characterization, 20 µM of Ac-XEXD-Afc fluorogenic peptidic substrates were incubated in caspase buffer alone, with cell extracts, or with cell extracts plus 0.5 nM recombinant WT caspase-3 as a positive control since this caspase is able to hydrolyze efficiently all caspase substrates used (7) . Afc hydrolysis rates were recorded in continuous mode on an Infinity M1000 platereader (TECAN). Bir2 inhibition assays were performed as previously described (1) Caspase affinity columns. IMAC resin (200 µl) was saturated with purified 6xHis-tagged caspase and washed with PBS. RNA or DNA (7.2 µg) in 200 µl PBS (36 ng/µl) was loaded onto the column, washed three times with 200 µl PBS to remove unbound nucleic acids, and nucleic acids were eluted with PBS plus 1.25 M NaCl. The flow-through from the loading, the washing steps, and the eluate were kept for further quantification. A sample from each column eluate was separated on an agarose gel alongside the input RNA or DNA to visualize the bound nucleic acids.
Gel shift assays. Five µM of each caspase were incubated alone or with 1 µg of RNA in 30 µl for 30 min in a buffer containing 50 mM Tris (pH 7.2), 100 mM NaCl, 10 units of RNasein, and 10 mM DTT. Glycerol was added to a final concentration of 5% (v/v) before separating the samples on a native agarose gel containing SYBR Safe (Invitrogen) for 40 min at 120 V in TBE buffer (45 mM Tris base, 45 mM boric acid, and 1 mM EDTA). RNA was visualized using a VersaDoc 4000mp imaging system. Then, the gel content was transferred to a PVDF membrane using a modified Southern blotting method with a PVDF membrane and the transfer buffer used for immunoblotting (see composition above); transfer was performed overnight by capillarity. Subsequently, membranes were processed for immunoblotting. Agard et al. (11) were reanalyzed to compare the number of RNA-binding substrates for each caspase. Proteins were classified as RNA-binding or other based on their Gene Ontology Molecular functions listed in the UniProtKB database (http://www.uniprot.org) and were counted only once even if they had more than one cleavage site. The chi-square statistical test was used to determine the difference in protein distribution between caspase-3 and caspase-7. Fig. S3 . Prior to performing the cleavage assays, extracts were 1) left untreated; 2) treated with RNase; 3) treated with RNase, then with RNasein to inhibit RNase and supplemented with intact RNA; 4) incubated with RNasein-inhibited RNase as a control; 5) incubated with RNasein alone as a control; or 6) supplemented with fragmented RNA obtained from RNA treated with RNase; after treatment, RNase was inhibited with RNasein. (B) RNA and RNase have no effect on the intrinsic activity of caspase-7. Kinetic parameters for WT caspase-7 alone, with BSA, with RNA, with RNase, or with digested RNA were determined using the small fluorogenic peptidic substrate Ac-DEVD-Afc. Both the substrate saturation curve fit (Michaelis-Menten) and the values for the individual kinetic parameter ± error on the fit are shown. Open arrow denotes a sample with ~50% cleavage out of caspase concentration range. .  Table S2 . Analysis of caspase-7's and caspase-3's substrates previously identified by Agard et al. (11) .
RNA-binding proteins substrate analysis. Data for caspase-3 and caspase-7 substrates and relative cleavage rates determined by

Supporting figures
Substrates for DNA-BPs Others Significance
Caspase-7 12.3% (7/57) 87.7% (50/57) p = 0.326 (Chi-square) Caspase-3 17.9% (30/168) 82.1% (138/168) Substrates were classified as DNA-binding proteins (DNA-BPs) or as others based on their Gene Ontology molecular functions in the UniProtKB database. The DNA-BP preference of caspase-7 and caspase-3 was analyzed using a c 2 test.
